← Back to headlines
Merck's Welireg Receives FDA Label Expansion for Kidney Cancer
Merck announced that its drug Welireg has received an FDA label expansion, allowing its use in treating kidney cancer.
12 Jun, 17:11 — 12 Jun, 17:11
Sources
Showing 1 of 1 sources
